Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2024-05-30 00:00:00 ET · period of report 2024-05-28 · accession 0000950170-24-066668 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-05-30 | 2024-05-28 | DLB | SHERMAN MARK ANDREW | EVP, Gen. Counsel, Sec | S - Sale+OE | $79.62 | -2,283 | 58.3K | -4% | -$181.8K |
| DT | 2024-05-30 | 2024-05-28 | DLB | SHERMAN MARK ANDREW | EVP, Gen. Counsel, Sec | M - OptEx | $62.32 | +1,998 | 60.6K | +3% | +$124.5K |
| DT | 2024-05-30 | 2024-05-28 | DLB | SHERMAN MARK ANDREW | EVP, Gen. Counsel, Sec | M - OptEx | $0.00 | -1,998 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-05-28 | S | D | 2,283 | $79.62 | 58,325 | D | — | — | (F2) Shares held following the reported transactions include 41,398 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| 2 | Common | Class A Common Stock | 2024-05-28 | M | A | 1,998 | $62.32 | 60,608 | D | — | — | (F1) Shares include 285 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2024. (F2) Shares held following the reported transactions include 41,398 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2024-05-28 | M | D | 1,998 | $0.00 | 0 | D | $62.32 · — to 2024-12-15 | 1,998 Class A Common Stock | (F3) This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 26,880 shares. The option exercised in this transaction was fully vested and exercisable as of the transaction date. |